Shamshad Ali, Irfan Ali Mirza, Sidra Yaqoob, Aamir Hussain, Inamullah Khan, Muhammad Yasir Rafiq


Background: Enterococci are the most common cause of healthcare associated urinary tract infections. The frequency of isolation of enterococci from urinary tract of hospitalized patients has risen. Vancomycin resistant enterococci along with other multidrug resistant bacteria are the main concerns for physicians. Enterococci may also act as vehicle for spread of resistant genes. The objective of this study was to determine the antimicrobial susceptibility pattern of different enterococcal species isolated from urine samples.
Material & Methods: This cross-sectional study was conducted at Department of Microbiology, Armed Forces Institute of Pathology, Rawalpindi. Hundred enterococcal isolates cultured from urinary specimens were processed from October 2011 to March 2012. In-vitro drug-susceptibility tests of enterococci isolated were performed on Mueller Hinton agar.
Results: A total of 100 urine specimens yielding growth of enterococci were studied. Among these only 7 samples were from OPD, the rest were from different wards. The mean age was 55±24.58 (range 8-89) years. Sixty-six (66%) of the isolates were from males while 34(34%) from females. Enterococcus faecalis was isolated in 81(81%) cases while Enterococcus faecium in 19(19%). Regarding sensitivity, 100% isolates were susceptible to linezolid, 99% to teicoplanin, 97% to vancomycin, 88% to imipenem, 87% to co-amoxiclav, 81% to nitrofurantoin, 75% to ampicillin, whereas the susceptibility to ciprofloxacin and tetracycline was 42% and 38% respectively.
Conclusion: Enterococci have emerged from being harmless commensals to versatile lethal pathogens. The rising antibiotics resistance is worrisome as the commonly used antibiotics for the treatment of nosocomial UTI are less effective.


Enterococcus; Enterococcus faecalis; Enterococcus faecium; Urinary tract infections; Urine culture; Antibiotics

Full Text:



Sood S, Malhotra M, Das BK, Kapil A. Enterococcal infections & antimicrobial resistance. Indian J Med Res 2008; 128:111-21.

Murray PR, Baron EJ, Jorgensen JH, Landry ML, Pfaller MA. Manual of clinical Microbiology. 10th ed. Washington D.C: ASM Press; 2011.

Upadhyaya PMG, Ravikumar KL, Umapathy BL. Review of virulence factors of enterococcus: An emerging nosocomial pathogen. Indian J Microbiol 2009; 27:301-5.

Mohamed JA, Huang DB. Biofilm formation by enterococci. J Mel Microbiol 2007; 56:1581-8.

Joyanes P, Pascual A, Martinez-Martinez L, Hevia A, Perea EJ. In vitro adherence of Enterococcus faecalis and Enterococcus faecium to urinary catheters. Eur J Clin Microbiol Infect Dis 2000; 19:124-7.

Shortliffe LMD, McCue JD. Urinary tract infection at the age extremes: pediatrics and geriatrics. Am J Med 2002; 113 Suppl 1A:55S-66S.

Karmarkar MG, Gershom ES, Mehta PR. Enterococcal infections with special reference to phenotypic characterization & drug resistance. Indian J Med Res 2004; 119 (Suppl): S22-S25.

Hidron AI, Edwards JR, Patel J, Horan TC, Sievert DM, Pollock DA, et al. Antimicrobial-resistant pathogens associated with healthcare-associated infections. Infect Control Hosp Epidemiol 2008; 29:996-1011.

Arias CA, Panesso D, McGrath DM, Qin X, Mojica MF, Miller C, et al. Genetic basis for in vivo daptomycin resistance in enterococci. N Engl J Med 2011; 365:892-900.

Pogue JM, Paterson DL, Pasculle AW, Potoski BA. Determination of risk factors associated with isolation of linezolid-resistant strains of vancomycin-resistant Enterococcus. Infect Control Hosp Epidemiol 2007; 28:1382-8.

Mohanty S, Jose S, Singhal R, Sood S, Dhawan B, Das BK, et al. Species prevalence and antimicrobial susceptibility of enterococci isolated in a tertiary care hospital of north India. Southeast Asian J Trop Med Public Health 2005; 36: 962-5.

Kahlmeter G. An international survey of the antimicrobial susceptibility of pathogens from uncomplicated urinary tract infections: the ECO.SENS Project. J Antimicrob Chemother 2003; 51:69-76. doi: 10.1093/jac/dkg028

Clinical and Laboratory Standards Institute. Performance Standards for Antimicrobial Susceptibility Testing; Twenty-Second Informational Supplement. Wayne, PA, USA 2012; 32 (3): M100 –S22.

Butt T, Leghari MJ, Mahmood A. In vitro activity of nitrofurantoin in enterococcus urinary tract infection. J Pak Med Assoc 2004; 54:466-9.

Barros M, Martinelli R, Rocha H. Enterococcal urinary tract infections in a university hospital: clinical studies. Braz J Infect Dis 2009; 13:294-6.

Shinde RS, Koppikar GV, Oommen S. Characterization and antimicrobial susceptibility pattern of clinical isolates of Enterococci at a tertiary care hospital in Mumbai, India. Ann Trop Med Public Health 2012; 5:85-8.


  • There are currently no refbacks.

Copyright (c) 2020 Shamshad Ali, Irfan Ali Mirza, Sidra Yaqoob, Aamir Hussain, Inamullah Khan, Muhammad Yasir Rafiq

Creative Commons License
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.